Introduction/Aim: Renal transplantation is the best and preferred way of treating patients with end-stage renal disease, as it offers improved survival and better quality of life in comparison to dialysis. The aim of this study is to show single-center results of the kidney allograft and patient survival during the period from 1996-2017. Methods: This is a retrospective, 22-year cohort study. Variables of interest were graft and patient survival in kidney transplanted patients. Age, gender, creatinine and induction therapy after transplantation were recorded in this group of patients as well. Results: Among 386 transplanted patiets, 316 patients had a living donor and 70 patients deceased donor. Preemptive renal transplantation is done in 29 or 7.5% patients and ABO-incompatible kidney transplantation in 21 or 5.4% patients. One-year, 5-year, 10-year and 20-year overall patient survival after kidney transplantation in the opserved group was 97.7%, 95.3%, 93.8% and 91.7%, respectively. One-year, 5-year, 10-year and 20-year graft survival in the our patinets were 93.8%, 85.5%, 78.5% and 73.3%, respectively. Conclusion: The outcome of graft and patient survival in Military Medical Academy kidney transplantation program are good and in the line with the most eminent world centers.